InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,401.20
(
0.41%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
75.01
(
1.72%
)
Bitcoin
63,599.88
(
0.44%
)
Post# of 116676
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Knowledge is King

Send PM Follow Ignore
Followers 349
Posts 13834
Boards Moderated 19
Alias Born 12/31/2004

Knowledge is King

Member Level

Re: Knowledge is King post# 64736

Wednesday, 02/12/2020 5:49:15 PM

Wednesday, February 12, 2020 5:49:15 PM

Post# of 116676
INBP($.23) impresses with Q2 EPS $.03 vs $.01, revenues up 18% to $14M. Twelve-month trailing earninga for this one are now $.083/share, suggesting a P/E of less than 3. Not bad for a company with 8 consecutive profitable quarters, and 7 consecutive quarters of year-over-year revenue growth...


https://www.otcmarkets.com/stock/INBP/news/Integrated-BioPharma-Reports-Results-for-its-Quarter-Ended-December-31-2019?id=253719

The moment a person forms a theory his imagination sees in every object only the traits which favor that theory. Thomas Jefferson

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up